Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

Affiliations

• ¹ Yale Cancer Center, 333 Cedar St, TMP 3, PO Box 208028, New Haven, CT, 06520-8028, USA. francine.foss@yale.edu.
• ² Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• ³ Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
• ⁴ Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
• ⁵ Moffitt Cancer Center, Tampa, FL, USA.
• ⁶ Veristat, LLC, Southborough, MA, USA.
• ⁷ Hospices Civils de Lyon, Lyon, France.